Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

The Era of Natural Antibiotics Toward 2050: First Part

Author(s): Luigi Santacroce and Emilio Jirillo

Volume 28, Issue 35, 2022

Published on: 13 October, 2022

Page: [2855 - 2855] Pages: 1

DOI: 10.2174/138161282835221013110056

Price: $65

Next »
[1]
Sing AK, Prajapati KS, Kumar S. Acarbose potentially binds to the type I peptide deformylase catalytic site and inhibits bacterial growth: An in silico and in vitro study. Curr Pharm Des 2022; 28(35): 2890-900.
[2]
Moretta A, Scieuzo C, Salvia R, Popovic ZD, Sgambato A, Falabella P. Tools in era of multidrug resistance in bacteria: Applications for new antimicrobial peptides discovery. Curr Pharm Des 2022; 28(35): 2856-66.
[3]
Kontogiannis T, Dimitriou TG, Didaras NA, Mossialos D. Antiviral activity of bee products. Curr Pharm Des 2022; 28(35): 2867-78.
[4]
Santacroce L, Spirito F, Bottalico L, et al. Current issues and perspectives in antimicrobials use in dental practice. Curr Pharm Des 2022; 28(35): 2879-89.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy